DUBLIN, May 26, 2022 /PRNewswire/ — The “Pediatric Imaging Technology Innovation and Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.
This study highlights market growth drivers and restraints and technology innovation in pediatric imaging devices.
The research service outlines important pediatric imaging innovation and developments. The technology scope covers pediatric X-ray, magnetic resonance imaging (MRI), and computed tomography (CT).
Imaging is an important element in the clinical evaluation of pediatric patients, and it helps in better diagnosis and treatment of different medical conditions. However, pediatric patients are more radiosensitive than adults, and excessive radiation exposure puts them at risk of developing cancer.
In addition, the imaging device settings used for adults cannot be used for pediatric patients. While several imaging devices focus on pediatric patients, the publisher identifies and analyzes the developments in the space that address current unmet needs such as radiation-free imaging; radiation adjustment based on the size of the pediatric patient; the need for patient transportation to the radiology department; and the need for disturbance (low noise)-free imaging devices.
The study also analyzes the competitive landscape; the key partnerships and collaborations; funding activities; and the patent landscape. It identifies important growth opportunities for market participants that they can leverage to gain business advantages.
The geographic scope is global; however, more weightage is given to the US market due to the significant activities observed in the area.
Key Questions This Study Answers:
What are the clinical needs in the pediatric imaging space? What are the market growth drivers and restraints?
What are the key innovations in X-ray, CT, and MRI technology? What does the application landscape look like in each of these imaging technologies?
What does the competitive landscape look like?
Which pediatric imaging devices received FDA approvals in 2020-2021?
What important partnerships and collaborations and funding activities have taken place in the recent past? What important pediatric imaging patents have been filed/published over the past 2 years?
Key Topics Covered:
1. Strategic Imperatives
Why Is It Increasingly Difficult to Grow? The Strategic Imperative: Factors Creating Pressure on Growth
The Strategic Imperative
The Impact of the Top Three Strategic Imperatives on the Pediatric Imaging Industry
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Environment
Scope of Analysis
Pediatric Imaging Involves the Use of Low-radiation Doses to Examine Normalities and Abnormalities in Children
Pediatric Imaging – Technology Segmentation
Pediatric Imaging – Key Applications
The Use of Imaging Devices Primarily Designed for the Adult Population and the Transportation of Pediatric Patients to Radiology Departments are Major Challenges
Technology Innovation Should Focus on Radiation Exposure Reduction, Improved Diagnosis Accuracy, and Enhanced Pediatric Patient Experiences
3. Technology Segmentation – Pediatric X-ray Imaging
Pediatric X-ray Imaging: Fast and Comfortable Imaging Technology that Uses Small Doses of Ionizing Radiation to Generate Images of the Body
Mobile X-ray Systems and the Integration of AI Technology are Important Innovations in Pediatric X-ray Imaging
Important Design Innovation and the Integration of AI in Pediatric X-ray Imaging
X-ray is the First Imaging Technology Used to Detect Complications or Disorders in Pediatric Patients
US FDA Guidance Encourages Manufacturers to Consider Pediatric Patients’ Safety While Designing X-ray Imaging Devices
US FDA Guidance Recommends the Enhancement of 510(k) Submissions for X-ray Systems by Mentioning the Details of Pediatric Patient Applications as Different Segments
4. Technology Segmentation – Pediatric Computed Tomography (CT) Imaging
Pediatric CT Imaging: Fast, Noninvasive, and Comfortable Imaging that Uses a Series of X-rays to Create High-quality Images of the Patient’s Body
Innovative Pediatric CT Imaging Technologies Focus on the Reduction of Radiation and the Improvement of Image Quality
Key Innovation in Dose Reduction in Pediatric CT Imaging
Pediatric CT Imaging is Used to Obtain an In-depth Diagnosis of a Wide Range of Conditions Due to Injury or Illness
Healthcare Providers, CT Technologists & Device Manufacturers, and Medical & Government Organizations Should Take Equal Responsibility to Minimize CT Radiation in the Pediatric Patients
Long-term Measures will Encourage the Use of Selective Strategies and Boost Awareness in terms of Minimizing CT Radiation in Pediatric Imaging Procedures
European Guidelines Strongly Recommend the Use of DRLs For Pediatric Imaging Based on Patient Age, Size, or Weight
5. Technology Segmentation – Pediatric Magnetic Resonance Imaging (MRI)
Pediatric MRI Technology: Uses Magnetic Fields and Radio Waves to Produce High-quality Images of the Inside of a Patient’s Body
Innovation Focuses on the Development of Mobile Systems and the Enhancement of the Pediatric Patient Experience during Procedures
Key Innovation in Device Design in Pediatric MRI
Pediatric MRI is Used to Detect Abnormalities Related to the Brain, Spinal Cord, Chest, Lungs, Pelvic Region, and Skeleton
MRI Techniques Hold the Potential to Enhance Image Quality, Reduce Imaging Time, and Minimize Sedation Requirements
Fast MRI Techniques Such as Parallel Imaging and SMS Imaging Significantly Reduce Acquisition Time
6. Industry Assessment and Analysis
Pediatric Imaging is a Fragmented Market that Comprises Large Companies and Emerging Start-ups
Pediatric Imaging Competitive Landscape – Explanation
Companies Use Partnerships and Collaborations, Mergers and Acquisitions for Expansion, and Technology Development to Maintain a Competitive Edge
Recent Regulatory Approvals for Pediatric Imaging Devices
Partnerships and Collaborations will Increase the Availability of Imaging Devices and Improve Patient Experiences During Procedures
Technology Partnerships for AI Usage are Increasing, and They will Enhance the Interpretation of Images by Radiologists and Technicians
Key Funding Activity
Compact MRI Systems Increase Patient Comfort and Reduce Disturbances due to Noise and Patient Movement
Functional Neuroimaging Packages will Enable Noninvasive Neural Activity Recording
Portable and Compact Mobile X-ray Systems will Deliver High Performance
7. Patent Landscape
The Development of Imaging Device Components and the Integration of AI/ML are the Focus of Innovation
8. Growth Opportunity Universe
Growth Opportunity 1: Compact and Portable MRI Devices for the Bedside Imaging of Multiple Organs
Growth Opportunity 2: Teleradiology Solutions and Global Pediatric Imaging Networks for Remote Consultation and Knowledge Sharing
Growth Opportunity 3: AI-enabled Imaging Devices for Faster Image Interpretation to Reduce Pediatric Imaging Procedure Time
9. Next Steps
For more information about this report visit https://www.researchandmarkets.com/r/1qqms1
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-pediatric-imaging-technology-report-2022-portable-mobile-imaging-devices-technologies-that-lower-dose-exposure-and-the-use-of-ai-and-gamification-to-revolutionize-the-market-301556016.html
SOURCE Research and Markets
There are two sides to every coin. For penny stocks, or tickers that trade for less than $5 per share, this rings especially true. As some of the most divisive names on the Street, they are either met with resounding praise or forceful discontent. Going beyond the argument that you get more for your money, even minor price appreciation can result in massive percentage gains. However, some investors prefer to avoid these stocks entirely, as the fact that shares are trading at such depressed level
After the market closed Wednesday, Repare Therapeutics (NASDAQ: RPTX) announced that it had entered into a licensing and collaboration deal with Roche (OTC: RHHBY) for its experimental cancer drug, camonsertib, also known as RP-3500. In the wake of that news, Repare shares skyrocketed, and were up by 36.5% as of 11:58 a.m. ET on Thursday. The spectacular gain for Repare Thursday seems to be warranted, especially in light of the details of its agreement with the Swiss healthcare giant.
Did markets hit a turning point? The past couple of months brought us a seven-week losing streak in stocks, the longest such streak in over a decade, but the week before the Memorial Day holiday weekend saw strong gains. The S&P 500 wiped out its May losses. Post-holiday trading shows that some of these gains are continuing. If so, then it makes this the ideal time to ‘buy the dip,’ to get in while stocks remain at low cost, with attractive entry points. That’s the view from investment firm JPMo
"For many Disabled people, food delivery services are imperative for our well-being; it’s not a luxury, but something we’re dependent on."View Entire Post ›
Photo Illustration by The Daily Beast/Tulsa Police DepartmentA 45-year-old man killed four people and himself at a medical office in Tulsa, Oklahoma, on Wednesday after complaining repeatedly about back pain following surgery, police said Thursday.The suspect was identified by police as Michael Louis, whose also went by Michelet Louis, his family told The Daily Beast.“Tulsa Police called me and verified that it’s my uncle,” Louis’ niece texted early Thursday morning. “We are so distraught.” She
Dr. Philip Toleikis, President and Chief Executive Officer, Sernova Corp. (TSXV: SVA) and his team joined Tanya Rowntree, Global Head of Client Success, Toronto Stock Exchange (TSX), to celebrate the company's graduation from TSX Venture Exchange to Toronto Stock Exchange and open the market.
Pfizer Inc. and BioNTech SE have asked the U.S. Food and Drug Administration to authorize their three-dose vaccine for children aged six months to five years, in a move that could add roughly 19 million young children to the program.
Regeneron will gain exclusive worldwide development, commercialization, and manufacturing rights to the drug Libtayo.
‘If the NHS does not acknowledge that things need to change then I feel sorry for everybody,’ Lois Walker says
Organon Canada Inc., an affiliate of Organon (NYSE: OGN), a global women's healthcare company, which employs over 120 people across Canada, today announced the publication of the company inaugural Environmental, Social, and Governance (ESG) Report for 2021. The ESG report introduces the company's ESG platform, known as Her Promise, and details how the company is working to help women and girls achieve the full potential of their promise through better health. The publication of the ESG Report an
Mothers said their mental health worsened in the past year during the pandemic, according to the poll.
Vertex Pharmaceuticals got an upgrade Wednesday on its burgeoning non-cystic fibrosis pipeline — as VRTX stock inched higher.
Michael Louis, the suspected shooter, is believed to have died by sucide after killing four at a hospital campus in Tulsa
The company asked 100,000 people to self-report data about long COVID; Shanghai exits lockdown; COVID-19 cases in the U.S. drop
Severe undercounting undermines our efforts to ‘understand and get ahead of the virus’, researcher says after New York survey
Amphastar Pharmaceuticals is the leading biotech stock, ranking first out of 799 companies in the industry.
A new study found those who drink coffee—both unsweetened and sugar-sweetened—have up to a 31% lower risk of death, compared to those who don’t drink coffee.
Police say a man who blamed his surgeon for ongoing pain after recent back surgery killed the surgeon and three others before fatally shooting himself.
The substances would remain illegal, but adults found in possession of up to 2.5 grams of the illicit substances will no longer be arrested, charged or have their drugs seized, according to an official statement. B.C., Canada's westernmost province and the epicenter of the country's overdose crisis, had requested the federal government for such an exemption in November. The exemption, a first in Canada, is intended to reduce the stigma associated with substance use and make it easier for people to approach law enforcement and other authorities to seek guidance.
The once-and-done gene therapy, initially rejected by the FDA in summer 2020, could potentially provide a genetic fix for a bleeding disorder that today can require multiple prophylactic injections a week.